Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs

被引:147
作者
Yang, J
Wu, J
Kowalska, MA
Dalvi, A
Prevost, N
O'Brien, PJ
Manning, D
Poncz, M
Lucki, I
Blendy, JA
Brass, LF
机构
[1] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA
[3] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA
[4] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1073/pnas.180194597
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Heterotrimeric G proteins mediate the earliest step in cell responses to external events by linking cell surface receptors to intracellular signaling pathways. G(z) is a member of the G(i) family of G proteins that is prominently expressed in platelets and brain. Here, we show that deletion of the a subunit of G(z) in mice: (i) impairs platelet aggregation by preventing the inhibition of cAMP formation normally seen at physiologic concentrations of epinephrine, and (ii) causes the mice to be more resistant to fatal thromboembolism. Loss of G(z alpha) also results in greatly exaggerated responses to cocaine, reduces the analgesic effects of morphine, and abolishes the effects of widely used antidepressant drugs that act as catecholamine reuptake inhibitors. These changes occur despite the presence of other G(i alpha) family members in the same cells and are not accompanied by detectable compensatory changes in the level of expression of other G protein subunits. Therefore, these results provide insights into receptor selectivity among G proteins and a model for understanding platelet function and the effects of psychoactive drugs.
引用
收藏
页码:9984 / 9989
页数:6
相关论文
共 37 条
[1]   ISLET-ACTIVATING PROTEIN IMPAIRS ALPHA-2-ADRENOCEPTOR-MEDIATED INHIBITORY REGULATION OF HUMAN-PLATELET ADENYLATE-CYCLASE [J].
AKTORIES, K ;
SCHULTZ, G ;
JAKOBS, KH .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1983, 324 (03) :196-200
[2]   REGULATION OF DEACTIVATION OF PHOTORECEPTOR G-PROTEIN BY ITS TARGET ENZYME AND CGMP [J].
ARSHAVSKY, VY ;
BOWNDS, MD .
NATURE, 1992, 357 (6377) :416-417
[3]   PARKINSONIAN-LIKE LOCOMOTOR IMPAIRMENT IN MICE LACKING DOPAMINE D2 RECEPTORS [J].
BAIK, JH ;
PICETTI, R ;
SAIARDI, A ;
THIRIET, G ;
DIERICH, A ;
DEPAULIS, A ;
LEMEUR, M ;
BORRELLI, E .
NATURE, 1995, 377 (6548) :424-428
[4]  
BORSINI F, 1988, PSYCHOPHARMACOLOGY, V94, P147
[5]  
CASEY PJ, 1990, J BIOL CHEM, V265, P2383
[6]  
CHAN JSC, 1995, J NEUROCHEM, V65, P2682
[7]  
DIMINNO G, 1983, J PHARMACOL EXP THER, V225, P57
[8]   ROLE OF D-1 AND D-2 RECEPTOR STIMULATION IN SENSITIZATION TO AMPHETAMINE-INDUCED CIRCLING BEHAVIOR AND IN EXPRESSION AND EXTINCTION OF THE PAVLOVIAN CONDITIONED-RESPONSE [J].
DREW, KL ;
GLICK, SD .
PSYCHOPHARMACOLOGY, 1990, 101 (04) :465-471
[9]   Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice [J].
Fabre, JE ;
Nguyen, MT ;
Latour, A ;
Keifer, JA ;
Audoly, LP ;
Coffman, TM ;
Koller, BH .
NATURE MEDICINE, 1999, 5 (10) :1199-1202
[10]   Nonselective coupling of the human μ-opioid receptor to multiple inhibitory G-protein isoforms [J].
Gaibelet, G ;
Meilhoc, E ;
Riond, J ;
Saves, I ;
Exner, T ;
Liaubet, L ;
Nürnberg, B ;
Masson, JM ;
Emorine, LJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1999, 261 (02) :517-523